BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8660654)

  • 1. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1.
    Liang H; Hittelman W; Nagarajan L
    Arch Biochem Biophys; 1996 Jun; 330(2):259-65. PubMed ID: 8660654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serine/threonine kinase Pim-1.
    Bachmann M; Möröy T
    Int J Biochem Cell Biol; 2005 Apr; 37(4):726-30. PubMed ID: 15694833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional attenuation of PIM-1 gene.
    Nagarajan L; Narayana L
    Biochem Biophys Res Commun; 1993 Jan; 190(2):435-9. PubMed ID: 8427586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
    Wingett D; Long A; Kelleher D; Magnuson NS
    J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
    Wingett D; Reeves R; Magnuson NS
    J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human PIM-1 gene product is a protein serine kinase.
    Padma R; Nagarajan L
    Cancer Res; 1991 May; 51(9):2486-9. PubMed ID: 1826633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
    Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
    Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
    Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
    J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger protein GFI-1 cooperates with myc and pim-1 in T-cell lymphomagenesis by reducing the requirements for IL-2.
    Zörnig M; Schmidt T; Karsunky H; Grzeschiczek A; Möröy T
    Oncogene; 1996 Apr; 12(8):1789-801. PubMed ID: 8622900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the pim-1 protooncogene: differential inducibility between alpha/beta- and gamma/delta-T cells and B cells.
    Wingett D; Stone D; Davis WC; Magnuson NS
    Cell Immunol; 1995 Apr; 162(1):123-30. PubMed ID: 7704900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the human and mouse PIM-1 cDNAs: nucleotide sequence and immunological identification of the in vitro synthesized PIM-1 protein.
    Domen J; Von Lindern M; Hermans A; Breuer M; Grosveld G; Berns A
    Oncogene Res; 1987 Jun; 1(1):103-12. PubMed ID: 3329709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG.
    Saris CJ; Domen J; Berns A
    EMBO J; 1991 Mar; 10(3):655-64. PubMed ID: 1825810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E.
    Hoover DS; Wingett DG; Zhang J; Reeves R; Magnuson NS
    Cell Growth Differ; 1997 Dec; 8(12):1371-80. PubMed ID: 9419425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained expression of the pim-1 kinase is specifically induced in myeloid cells by cytokines whose receptors are structurally related.
    Lilly M; Le T; Holland P; Hendrickson SL
    Oncogene; 1992 Apr; 7(4):727-32. PubMed ID: 1314369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Pim-1 function in mutant mice.
    Domen J; van der Lugt NM; Laird PW; Saris CJ; Berns A
    Leukemia; 1993 Aug; 7 Suppl 2():S108-12. PubMed ID: 8361211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.
    Lilly M; Sandholm J; Cooper JJ; Koskinen PJ; Kraft A
    Oncogene; 1999 Jul; 18(27):4022-31. PubMed ID: 10435626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells.
    Buckley AR; Buckley DJ; Leff MA; Hoover DS; Magnuson NS
    Endocrinology; 1995 Dec; 136(12):5252-9. PubMed ID: 7588268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
    Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
    Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of the human PIM-1 gene: a putative oncogene related to the protein kinases.
    Meeker TC; Nagarajan L; ar-Rushdi A; Croce CM
    J Cell Biochem; 1987 Oct; 35(2):105-12. PubMed ID: 3429489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.